CYTEIR THERAPEUTICS
CYT Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2024-03-20
2024-03-25
LEONARD BRADEN MICHAEL
P - Purchase
Common Stock, par value $0.001 per share
171K
$3.00
512K
1
$96.83M
2024-03-18
2024-03-19
LEONARD BRADEN MICHAEL
P - Purchase
Common Stock, par value $0.001 per share
114K
$3.00
341K
1
$96.83M
2024-03-04
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
6,304
$2.00
12,608
1
$96.83M
2024-03-04
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-2,373
$0.00
1
$96.83M
2024-03-04
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
2,373
$2.00
4,746
1
$96.83M
2024-03-04
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-6,304
$0.00
1
$96.83M
2024-02-29
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-7,985
$0.00
2
$96.83M
2024-02-29
2024-03-05
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
7,985
$2.00
15,970
2
$96.83M
2024-02-29
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-15,144
$0.00
2
$96.83M
2024-02-29
2024-03-05
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
15,144
$2.00
30,288
2
$96.83M
2023-12-11
2023-12-14
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-3,993
$0.00
2
$96.83M
2023-12-11
2023-12-14
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
3,993
$2.00
7,986
2
$96.83M
2023-12-11
2023-12-14
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-8,840
$0.00
2
$96.83M
2023-11-20
2023-12-14
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
8,840
$2.00
17,680
2
$96.83M
2023-11-20
2023-11-22
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-84,637
$0.00
2
$96.83M
2023-11-20
2023-11-22
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
73,940
$2.00
148K
2
$96.83M
2023-11-20
2023-11-22
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
84,637
$2.00
169K
2
$96.83M
2023-11-20
2023-11-22
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-73,940
$0.00
2
$96.83M
2023-02-03
2023-02-07
RENSCHLER MARKUS MD
President and CEO
A - Grant
Stock Option (Right to Buy)
303K
$0.00
1
$96.83M
2023-02-03
2023-02-07
GAIERO DAVID
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
114K
$0.00
1
$96.83M
2023-02-03
2023-02-07
VENESS ADAM
General Counsel
A - Grant
Stock Option (Right to Buy)
96,100
$0.00
1
$96.83M
2023-01-13
2023-02-07
RENSCHLER MARKUS MD
President and CEO
A - Grant
Common Stock
5,000
$1.00
5,000
1
$96.83M
2023-01-13
2023-02-07
GAIERO DAVID
Chief Financial Officer
A - Grant
Common Stock
5,000
$1.00
5,000
1
$96.83M
2021-12-20
2023-02-07
GAIERO DAVID
Chief Financial Officer
M - Exercise
Common Stock
4,100
$2.00
8,200
1
$96.83M
2021-12-20
2023-02-07
GAIERO DAVID
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-4,100
$0.00
1
$96.83M
2022-12-21
2022-12-23
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Stock Option (Right to Buy)
-137K
$0.00
2
$96.83M
2022-12-21
2022-12-23
RENSCHLER MARKUS MD
President and CEO
M - Exercise
Common Stock
137K
$1.00
137K
2
$96.83M
2022-05-02
2022-05-04
VENESS ADAM
General Counsel
A - Grant
Stock Option (Right to buy)
177K
$0.00
1
$96.83M
2022-02-22
2022-02-24
SECRIST JOHN PAUL
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
42,000
$0.00
1
$96.83M
2022-02-22
2022-02-24
GAIERO DAVID
Vice President, Finance
A - Grant
Stock Option (Right to Buy)
23,000
$0.00
1
$96.83M
2022-02-22
2022-02-24
GENGOS ANDREW
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
35,000
$0.00
1
$96.83M
2022-02-22
2022-02-24
RENSCHLER MARKUS MD
President and CEO
A - Grant
Stock Option (Right to Buy)
106K
$0.00
1
$96.83M
2021-06-22
2021-06-24
DROIA INVEST II SCSP
C - Conversion
Series B Convertible Preferred Stock
-10M
1
$96.83M
2021-06-22
2021-06-24
NAESENS JANWILLEM
C - Conversion
Series B Convertible Preferred Stock
-10M
1
$96.83M
2021-06-22
2021-06-24
NAESENS JANWILLEM
C - Conversion
Series C Convertible Preferred Stock
-1.11M
1
$96.83M
2021-06-22
2021-06-24
ROMBERGER TIMOTHY
C - Conversion
Series A Convertible Preferred Stock
-69,503
1
$96.83M
2021-06-22
2021-06-24
ROMBERGER TIMOTHY
C - Conversion
Series B Convertible Preferred Stock
-200K
1
$96.83M
2021-06-22
2021-06-24
ZAKRZEWSKI JOSEPH
C - Conversion
Series B Convertible Preferred Stock
-200K
1
$96.83M
2021-06-22
2021-06-24
DROIA INVEST II SCSP
C - Conversion
Series C Convertible Preferred Stock
-1.11M
1
$96.83M
2021-06-22
2021-06-23
NOVO HOLDINGS A/S
C - Conversion
SERIES C CONVERTIBLE PREFERRED STOCK
-1.55M
1
$96.83M
2021-06-22
2021-06-23
VENROCK ASSOCIATES VII, L.P.
C - Conversion
Series C Convertible Preferred Stock
-1.11M
1
$96.83M
2021-06-22
2021-06-23
NOVO HOLDINGS A/S
C - Conversion
SERIES B CONVERTIBLE PREFERRED STOCK
-14M
1
$96.83M
2021-06-22
2021-06-23
VENROCK ASSOCIATES VII, L.P.
C - Conversion
Series B Convertible Preferred Stock
-10M
1
$96.83M